Veterinary Medicines

Multimin Solution for Injection for Cattle

Authorised
  • Manganese carbonate
  • Zinc oxide
  • Copper(II) carbonate
  • Sodium selenite
Download as PDF

Product identification

Medicine name:
Multimin Solution for Injection for Cattle
Multimin Oplossing voor injectie
Multimin Solution injectable
Multimin Injektionslösung
Active substance:
  • Manganese carbonate
  • Zinc oxide
  • Copper(II) carbonate
  • Sodium selenite
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Manganese carbonate
    20.92
    milligram(s)
    /
    1.00
    millilitre(s)
  • Zinc oxide
    74.68
    milligram(s)
    /
    1.00
    millilitre(s)
  • Copper(II) carbonate
    26.09
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium selenite
    10.95
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Primary packaging: Clear Polyethylene Terephthalate (PET) bottle closed with grey bromobutyl rubber stopper sealed with aluminium cap.Package sizes: Cardboard box containing one vial of 500 ml
  • Primary packaging: Clear Polyethylene Terephthalate (PET) bottle closed with grey bromobutyl rubber stopper sealed with aluminium cap.Package sizes: Cardboard box containing one vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Warburton Technology Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biove
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V583733
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0322/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 13/09/2024
Download
French (PDF)
Published on: 13/09/2024
Download
German (PDF)
Published on: 13/09/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 13/09/2024
Download
French (PDF)
Published on: 13/09/2024
Download
German (PDF)
Published on: 13/09/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 13/09/2024
Download
French (PDF)
Published on: 13/09/2024
Download
German (PDF)
Published on: 13/09/2024
Download

Combined File of all Documents

English (PDF)
Published on: 25/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."